http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AR-049112-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_24e76490bed88751680a5fef9bc73892 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-57 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-565 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-565 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-57 |
| filingDate | 2005-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b42b6e8c6c49a15276c2d6be536e9cc9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0c3e52aaa48919aa5020d3af7a633a58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_47e9cdcc94e5d7701049a631ca99369c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e22ee719a1c5cfeabf6ecae177f91ba6 |
| publicationDate | 2006-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | AR-049112-A1 |
| titleOfInvention | COMPOSITIONS, METHODS AND KIT, FOR THE TREATMENT OF PREMENSTRUAL DYSPHORIC DISORDER |
| abstract | A method of treating a patient suffering from premenstrual dysphoric disorder comprising administering an effective amount of at least one progestin and at least one estrogen to said patient, wherein said effective amount is administered daily for at least 100 days. Said method in which 4micrograms of levonorgestrel is administered, or a dose of progestin of equal potency, and wherein the progestin is chlormadinone acetate, norethisterone acetate, cyproterone acetate, desogestrel, signodena, drospirenone, etonorgestrel, norgestimate, norelgestromin or levonorgestrel . Said estrogen is ethinyl estradiol, mestranol, estradiol, estriol, estrone or estrano. A set for treating a patient that comprises at least 100 dosage forms that individually comprise at least one progestin and at least one estrogen. Said set in which each of the dose forms comprises at least 4 micrograms of levonorgestrel or progestin dose form of equal potency, and wherein the dosage forms are tablets, capsules, or a combination of both. |
| priorityDate | 2004-05-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 47.